Subcutaneous injection of organophosphate (Fenitrothion)-Management of preventing the appearance of toxic symptoms: A case report.

Nakamura, Hitomi; Hirayama, Ichiro; Hiruma, Takahiro; Doi, Kent

Nakamura, Hitomi; Hirayama, Ichiro; Hiruma, Takahiro; Doi, Kent.

Afiliação

Nakamura H; Department of Emergency and Critical Care Medicine The University of Tokyo Tokyo Japan.
Hirayama I; Department of Emergency and Critical Care Medicine The University of Tokyo Tokyo Japan.
Hiruma T; Department of Emergency and Critical Care Medicine The University of Tokyo Tokyo Japan.
Doi K; Department of Emergency and Critical Care Medicine The University of Tokyo Tokyo Japan.

Clin Case Rep ; 9(7): e04424, 2021 Jul.

Article em En | MEDLINE | ID: mdl-34267910

ABSTRACT

ABSTRACT

There is a risk of unnecessary extensive incision because of swelling after the subcutaneous injection; however, removing completely the injected organophosphate by making a skin incision before the appearance of toxic symptoms could reduce sequelae.

Palavras-chave

acetylcholinesterase; organophosphate; poisoning; subcutaneous injection

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Revista: Clin Case Rep Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google